DropoutRateBlindingGoodClinicalPractice(GCP)PhaseIInstitutionalReviewBoard(IRB)RegulatoryAuthorityOpen-LabelTrialPhaseIITrialRegistryEligibilityCriteriaPhaseIVProtocolInformedConsentEfficacyEthicsCommitteeDataManagementPlaceboInterventionAdverseEventDataLockParallelStudyProtocolDeviationSourceDataVerificationPilotStudyDouble-BlindStudyTrialMonitorData SafetyMonitoringBoard(DSMB)ControlGroupSafetyProfileClinicalResearchCoordinatorPatientRecruitmentFollow-up VisitStandardOperatingProcedure(SOP)StatisticalAnalysisPlan(SAP)AdaptiveDesignCrossoverStudyEndpointRecruitmentTargetAuditTrailClinicalStudyReport(CSR)ScreeningVisitSurrogateEndpointClinicalEndpointPrincipalInvestigatorMulticenterTrialSponsorInvestigatorMeetingCaseReportForm(CRF)RandomizationPhaseIIIDropoutRateBlindingGoodClinicalPractice(GCP)PhaseIInstitutionalReviewBoard(IRB)RegulatoryAuthorityOpen-LabelTrialPhaseIITrialRegistryEligibilityCriteriaPhaseIVProtocolInformedConsentEfficacyEthicsCommitteeDataManagementPlaceboInterventionAdverseEventDataLockParallelStudyProtocolDeviationSourceDataVerificationPilotStudyDouble-BlindStudyTrialMonitorData SafetyMonitoringBoard(DSMB)ControlGroupSafetyProfileClinicalResearchCoordinatorPatientRecruitmentFollow-up VisitStandardOperatingProcedure(SOP)StatisticalAnalysisPlan(SAP)AdaptiveDesignCrossoverStudyEndpointRecruitmentTargetAuditTrailClinicalStudyReport(CSR)ScreeningVisitSurrogateEndpointClinicalEndpointPrincipalInvestigatorMulticenterTrialSponsorInvestigatorMeetingCaseReportForm(CRF)RandomizationPhaseIII

Clinical Trials Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
  1. Dropout Rate
  2. Blinding
  3. Good Clinical Practice (GCP)
  4. Phase I
  5. Institutional Review Board (IRB)
  6. Regulatory Authority
  7. Open-Label Trial
  8. Phase II
  9. Trial Registry
  10. Eligibility Criteria
  11. Phase IV
  12. Protocol
  13. Informed Consent
  14. Efficacy
  15. Ethics Committee
  16. Data Management
  17. Placebo
  18. Intervention
  19. Adverse Event
  20. Data Lock
  21. Parallel Study
  22. Protocol Deviation
  23. Source Data Verification
  24. Pilot Study
  25. Double-Blind Study
  26. Trial Monitor
  27. Data Safety Monitoring Board (DSMB)
  28. Control Group
  29. Safety Profile
  30. Clinical Research Coordinator
  31. Patient Recruitment
  32. Follow-up Visit
  33. Standard Operating Procedure (SOP)
  34. Statistical Analysis Plan (SAP)
  35. Adaptive Design
  36. Crossover Study
  37. Endpoint
  38. Recruitment Target
  39. Audit Trail
  40. Clinical Study Report (CSR)
  41. Screening Visit
  42. Surrogate Endpoint
  43. Clinical Endpoint
  44. Principal Investigator
  45. Multicenter Trial
  46. Sponsor
  47. Investigator Meeting
  48. Case Report Form (CRF)
  49. Randomization
  50. Phase III